Altaris Combines Kindeva Drug Delivery and Meridian Medical Technologies

Altaris Acquires Clarivate Life Sciences & Healthcare Segment

October 6, 2026

Data & Analytics

Altaris acquired Clarivate’s Life Sciences & Healthcare segment for $600 million. Clarivate said the completed divestiture advances its strategic transformation, simplifies its portfolio, and provides proceeds to reduce debt and strengthen its balance sheet.

Analogic and Leidos Combine Security Businesses in Joint Venture

April 15, 2026

Manufacturing

Altaris-backed Analogic and Leidos agreed to combine Analogic Corporation with Leidos’ Security Enterprise Solutions (SES), Ports & Borders, and Industrial Automation businesses to create a global security imaging and detection company. Leidos contributed approximately 1,500 employees and retained significant minority ownership; the combination was completed on October 5, 2026.

Altaris Acquires Minaris Regenerative Medicine from Resonac

September 23, 2024

Healthcare Services

Altaris, LLC has acquired Minaris Regenerative Medicine from Resonac Corporation, making Minaris a wholly owned portfolio company of Altaris. Minaris is a cell therapy CDMO with six facilities across the United States, Germany and Japan and more than 500 employees; the deal advances Altaris' strategic initiative to build capabilities in cell and gene therapy manufacturing.

Kindeva Drug Delivery Acquires Summit Biosciences

January 18, 2024

Healthcare Services

Kindeva Drug Delivery, an operating company of Altaris, LLC, acquired Summit Biosciences, a specialized intranasal drug-delivery contract development and manufacturing organization (CDMO), from its founding family shareholders. The deal expands Kindeva’s drug-delivery capabilities with a new intranasal drug-delivery platform and adds Summit’s FDA- and EMA-approved cGMP facility in Lexington, Kentucky.

Altaris Capital Partners Acquires Meridian Medical Technologies from Pfizer

December 30, 2021

Medical Devices

Altaris Capital Partners has entered into an agreement to acquire Meridian Medical Technologies from Pfizer. Meridian, a pioneer in emergency response drug-device combination products and auto-injectors with facilities in St. Louis, Missouri and Columbia, Maryland and more than 750 employees, will become an Altaris portfolio company to expand the firm's capabilities in medical countermeasures and emergency response solutions.

Altaris Capital Partners Acquires Kindeva Drug Delivery from 3M

May 1, 2020

Medical Devices

Altaris Capital Partners has acquired Kindeva Drug Delivery L.P. (formerly 3M Drug Delivery Systems) from 3M Company for $650 million in a corporate carve-out transaction. Monroe Capital provided financing and an equity co-investment to support the deal, and 3M will retain a minority interest alongside Altaris as Kindeva operates independently to pursue growth and capital investments.